{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T16:38:45Z","timestamp":1777653525908,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T00:00:00Z","timestamp":1473984000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. National Institutes of Health","doi-asserted-by":"crossref","award":["EY018815"],"award-info":[{"award-number":["EY018815"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100001209","name":"Knights Templar Eye Foundation","doi-asserted-by":"publisher","award":["EY023968"],"award-info":[{"award-number":["EY023968"]}],"id":[{"id":"10.13039\/100001209","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.exer.2016.09.003","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T20:46:23Z","timestamp":1473885983000},"page":"77-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":34,"special_numbering":"C","title":["Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis"],"prefix":"10.1016","volume":"152","author":[{"given":"Christopher J.","family":"Tracy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca E.H.","family":"Whiting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacqueline W.","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Baye G.","family":"Williamson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniella P.","family":"Vansteenkiste","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren E.","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leilani J.","family":"Castaner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey N.","family":"Bryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan R.","family":"Coates","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl A.","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2582-9187","authenticated-orcid":false,"given":"Martin L.","family":"Katz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2016.09.003_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/ajmg.1320310615","article-title":"The Newfoundland aggregate of neuronal ceroid-lipofuscinosis","author":"Andermann","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.exer.2016.09.003_bib2","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.ymgme.2006.02.016","article-title":"A\u00a0frame shift mutation in canine TPP1 (the ortholog of human CLN2) in a juvenile Dachshund with neuronal ceroid lipofuscinosis","volume":"89","author":"Awano","year":"2006","journal-title":"Mol. Genet. Metab."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.exer.2016.09.003_bib3","first-page":"S9","article-title":"The endosomal network","volume":"47","author":"Brooks","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2016.09.003_bib4","doi-asserted-by":"crossref","first-page":"135","DOI":"10.33588\/rn.4003.2003615","article-title":"Clinical and electroencephalographic aspects of late infantile neuronal ceroid lipofuscinosis","volume":"40","author":"Caraballo","year":"2005","journal-title":"Rev. Neurol."},{"key":"10.1016\/j.exer.2016.09.003_bib5","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/mt.2008.9","article-title":"Intraventricular enzyme replacement improves disease phenotypes in a mouse model of late infantile neuronal ceroid lipofuscinosis","volume":"16","author":"Chang","year":"2008","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2016.09.003_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1017\/S1462399408000550","article-title":"The mucopolysaccharidoses: a success of molecular medicine","volume":"10","author":"Clarke","year":"2008","journal-title":"Expert Rev. Mol. Med."},{"key":"10.1016\/j.exer.2016.09.003_bib7","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1080\/00325481.2015.1052523","article-title":"Current intravitreal pharmacologic therapies for diabetic macular edema","volume":"127","author":"Colucciello","year":"2015","journal-title":"Postgrad. Med."},{"key":"10.1016\/j.exer.2016.09.003_bib8","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1097\/IAE.0000000000000520","article-title":"Sustained elevation of intraocular pressure after intravitreal anti-vegf agents: what is the evidence?","volume":"35","author":"Dedania","year":"2015","journal-title":"Retina"},{"key":"10.1016\/j.exer.2016.09.003_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10633-013-9388-8","article-title":"Guidelines for clinical electroretinography in the dog: 2012 update","volume":"127","author":"Ekesten","year":"2013","journal-title":"Doc. Ophthalmol."},{"key":"10.1016\/j.exer.2016.09.003_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diff.2012.08.004","article-title":"Mesenchymal stem cells and their use in therapy: what has been achieved?","volume":"85","author":"Fernandez Vallone","year":"2013","journal-title":"Differentiation"},{"key":"10.1016\/j.exer.2016.09.003_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.acthis.2015.02.005","article-title":"Wharton's jelly derived mesenchymal stromal cells: biological properties, induction of neuronal phenotype and current applications in neurodegeneration research","volume":"117","author":"Frausin","year":"2015","journal-title":"Acta Histochem."},{"key":"10.1016\/j.exer.2016.09.003_bib12","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1939-1676.2006.tb02868.x","article-title":"A\u00a0combination chemotherapy protocol with dose intensification and autologous bone marrow transplant (VELCAP-HDC) for canine lymphoma","volume":"20","author":"Frimberger","year":"2006","journal-title":"J.\u00a0Veterinary Intern. Med."},{"key":"10.1016\/j.exer.2016.09.003_bib13","doi-asserted-by":"crossref","first-page":"252","DOI":"10.3109\/08820538.2013.859280","article-title":"Pharmacologic therapy for diabetic retinopathy","volume":"30","author":"Gardlik","year":"2015","journal-title":"Seminars Ophthalmol."},{"key":"10.1016\/j.exer.2016.09.003_bib14","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2174\/092986707782794005","article-title":"Mannose 6-phosphate receptor targeting and its applications in human diseases","volume":"14","author":"Gary-Bobo","year":"2007","journal-title":"Curr. Med. Chem."},{"issue":"Suppl.\u00a01","key":"10.1016\/j.exer.2016.09.003_bib15","first-page":"S18","article-title":"Intracellular trafficking of lysosomal proteins and lysosomes","volume":"47","author":"Hasilik","year":"2009","journal-title":"Int. J. Clin. Pharmacol. Ther."},{"key":"10.1016\/j.exer.2016.09.003_bib16","doi-asserted-by":"crossref","first-page":"67","DOI":"10.2460\/ajvr.2005.66.67","article-title":"Assessment of retinal function and characterization of lysosomal storage body accumulation in the retinas and brains of Tibetan Terriers with ceroid-lipofuscinosis","volume":"66","author":"Katz","year":"2005","journal-title":"Am. J. Vet. Res."},{"key":"10.1016\/j.exer.2016.09.003_bib17","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.1167\/iovs.08-1712","article-title":"Retinal pathology in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"49","author":"Katz","year":"2008","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2016.09.003_bib18","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/jnr.23423","article-title":"Enzyme replacement therapy attenuates disease progression in a canine model of late-infantile neuronal ceroid lipofuscinosis (CLN2 disease)","volume":"92","author":"Katz","year":"2014","journal-title":"J.\u00a0Neurosci. Res."},{"key":"10.1016\/j.exer.2016.09.003_bib19","doi-asserted-by":"crossref","first-page":"313ra180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2016.09.003_bib20","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.stem.2015.02.019","article-title":"Mesenchymal cell contributions to the stem cell niche","volume":"16","author":"Kfoury","year":"2015","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.exer.2016.09.003_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1096\/fasebj.1.6.3315809","article-title":"Trafficking of lysosomal enzymes","volume":"1","author":"Kornfeld","year":"1987","journal-title":"Faseb J."},{"key":"10.1016\/j.exer.2016.09.003_bib22","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s40259-014-0108-z","article-title":"Elosulfase Alfa: a review of its use in patients with mucopolysaccharidosis type IVA (Morquio A syndrome)","volume":"28","author":"Lyseng-Williamson","year":"2014","journal-title":"BioDrugs"},{"key":"10.1016\/j.exer.2016.09.003_bib23","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1146\/annurev-physiol-012110-142317","article-title":"Lysosomal acidification mechanisms","volume":"74","author":"Mindell","year":"2012","journal-title":"Annu. Rev. Physiol."},{"key":"10.1016\/j.exer.2016.09.003_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s40264-015-0273-0","article-title":"Comparative safety and tolerability of anti-VEGF therapy in age-related macular degeneration","volume":"38","author":"Modi","year":"2015","journal-title":"Drug Saf."},{"key":"10.1016\/j.exer.2016.09.003_bib25","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"Mole","year":"2011"},{"key":"10.1016\/j.exer.2016.09.003_bib26","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.clinthera.2011.12.017","article-title":"Velaglucerase alfa for the management of type 1 Gaucher disease","volume":"34","author":"Morris","year":"2012","journal-title":"Clin. Ther."},{"key":"10.1016\/j.exer.2016.09.003_bib27","doi-asserted-by":"crossref","first-page":"68","DOI":"10.2174\/138920310790274644","article-title":"Evolution of mannose 6-phosphate receptors (MPR300 and 46): lysosomal enzyme sorting proteins","volume":"11","author":"Nadimpalli","year":"2010","journal-title":"Curr. Protein Pept. Sci."},{"key":"10.1016\/j.exer.2016.09.003_bib28","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/rej.2013.1407","article-title":"Human beta-glucuronidase: structure, function, and application in enzyme replacement therapy","volume":"16","author":"Naz","year":"2013","journal-title":"Rejuvenation Res."},{"key":"10.1016\/j.exer.2016.09.003_bib29","doi-asserted-by":"crossref","first-page":"263","DOI":"10.3109\/08820538.2014.959195","article-title":"Complications of subspecialty ophthalmic care: systemic complications from the intravitreal administration of agents that target the vascular endothelial growth factor pathway","volume":"29","author":"Ramsey","year":"2014","journal-title":"Seminars Ophthalmol."},{"key":"10.1016\/j.exer.2016.09.003_bib30","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1601-183X.2011.00718.x","article-title":"A\u00a0reversal learning task detects cognitive deficits in a Dachshund model of late-infantile neuronal ceroid lipofuscinosis","volume":"10","author":"Sanders","year":"2011","journal-title":"Genes Brain Behav."},{"key":"10.1016\/j.exer.2016.09.003_bib31","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"Sands","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2016.09.003_bib32","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.nurt.2008.08.009","article-title":"Therapeutic approaches in glycogen storage disease type II\/Pompe disease","volume":"5","author":"Schoser","year":"2008","journal-title":"Neurotherapeutics"},{"key":"10.1016\/j.exer.2016.09.003_bib33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1517\/17425247.2013.859135","article-title":"Drug delivery techniques for treating age-related macular degeneration","volume":"11","author":"Schwartz","year":"2014","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.exer.2016.09.003_bib34","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3109\/08820538.2014.962167","article-title":"Complications of intravitreal injections in patients with diabetes","volume":"29","author":"Shikari","year":"2014","journal-title":"Seminars Ophthalmol."},{"key":"10.1016\/j.exer.2016.09.003_bib35","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1126\/science.277.5333.1802","article-title":"Association of mutations in a lysosomal protein with classical late-infantile neuronal ceroid lipofuscinosis","volume":"277","author":"Sleat","year":"1997","journal-title":"Science"},{"key":"10.1016\/j.exer.2016.09.003_bib36","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.ophtha.2015.09.002","article-title":"Intravitreal bevacizumab versus ranibizumab for treatment of neovascular age-related macular degeneration: findings from a cochrane systematic review","volume":"123","author":"Solomon","year":"2016","journal-title":"Ophthalmology"},{"key":"10.1016\/j.exer.2016.09.003_bib37","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s12886-015-0017-z","article-title":"Ranibizumab for macular edema secondary to retinal vein occlusion: a meta-analysis of dose effects and comparison with no anti-VEGF treatment","volume":"15","author":"Song","year":"2015","journal-title":"BMC Ophthalmol."},{"key":"10.1016\/j.exer.2016.09.003_bib38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1002\/ajmg.1320570207","article-title":"Childhood neuronal ceroid-lipofuscinoses in Argentina","volume":"57","author":"Taratuto","year":"1995","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.exer.2016.09.003_bib39","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/bjh.12804","article-title":"Gaucher disease: haematological presentations and complications","volume":"165","author":"Thomas","year":"2014","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.exer.2016.09.003_bib40","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1007\/978-3-319-17121-0_76","article-title":"Intravitreal implantation of genetically modified autologous bone marrow-derived stem cells for treating retinal disorders","volume":"854","author":"Tracy","year":"2015","journal-title":"Adv. Exp. Biol. Med."},{"key":"10.1016\/j.exer.2016.09.003_bib41","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.ymgme.2011.06.018","article-title":"Intrathecal tripeptidyl-peptidase 1 reduces lysosomal storage in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"104","author":"Vuillemenot","year":"2011","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.exer.2016.09.003_bib42","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ymgme.2014.09.004","article-title":"Nonclinical evaluation of CNS-administered TPP1 enzyme replacement in canine CLN2 neuronal ceroid lipofuscinosis","volume":"114","author":"Vuillemenot","year":"2015","journal-title":"Mol. Genet. Metab."},{"key":"10.1016\/j.exer.2016.09.003_bib43","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.exer.2013.10.006","article-title":"Pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"116","author":"Whiting","year":"2013","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.09.003_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.exer.2014.06.008","article-title":"Enzyme replacement therapy delays pupillary light reflex deficits in a canine model of late infantile neuronal ceroid lipofuscinosis","volume":"125","author":"Whiting","year":"2014","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.09.003_bib45","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.exer.2015.02.012","article-title":"Multifocal retinopathy in Dachshunds with CLN2 neuronal ceroid lipofuscinosis","volume":"134","author":"Whiting","year":"2015","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.09.003_bib46","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.exer.2016.03.023","article-title":"Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease","volume":"146","author":"Whiting","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2016.09.003_bib47","doi-asserted-by":"crossref","first-page":"1R","DOI":"10.1093\/glycob\/cwi041","article-title":"Lysosomal metabolism of glycoproteins","volume":"15","author":"Winchester","year":"2005","journal-title":"Glycobiology"},{"key":"10.1016\/j.exer.2016.09.003_bib48","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1042\/BST0381484","article-title":"Current therapies for the soluble lysosomal forms of neuronal ceroid lipofuscinosis","volume":"38","author":"Wong","year":"2010","journal-title":"Biochem. Soc. Trans."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483516302536?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483516302536?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T18:51:44Z","timestamp":1749581504000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483516302536"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":48,"alternative-id":["S0014483516302536"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2016.09.003","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal implantation of TPP1-transduced stem cells delays retinal degeneration in canine CLN2 neuronal ceroid lipofuscinosis","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2016.09.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}